Register for email alerts and news feeds:
This journal | BMJ Group
rss
Ann Rheum Dis. Published Online First: 22 October 2009. doi:10.1136/ard.2009.111021
Copyright © 2009 BMJ Publishing Group Ltd & European League Against Rheumatism.

Extended Report

Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function

Velia Gerl1, Alexandra Lischka1, Daniel Panne1, Patrick Großmann1, Rita Berthold1, Bimba Franziska Hoyer1, Robert Biesen2, Anne Bruns2, Tobias Alexander2, Annett Jacobi2, Thomas Dörner3, Gerd-Rüdiger Burmester2, Andreas Radbruch4, Falk Hiepe2,*

1 Department of Rheumatology and Clinical Immunology, Charité University Hospital and German Rheumati, Germany;
2 Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany;
3 Institute of Transfusion Medicine, Charité University Hospital, Berlin, Germany;
4 German Rheumatism Research Centre, Berlin, Germany

Correspondence to: Falk Hiepe, Rheumatology & Clin. Immunology, Charité - Universitätsmedizin Berlin, Medizinische Klinik m.S. Rheumatologie u. Klin. Immunologie, Campus Charité Mitte, Charitéplatz 1, Berlin, D-10117, Germany; falk.hiepe{at}charite.de

Accepted 4 October 2009

ABSTRACT

Objectives: Dendritic cells (DCs) play a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE). Reduced numbers of blood DCs and the accumulation of DCs at inflammatory sites have been observed in SLE. One crucial feature of DCs is their ability to migrate. We analyzed thematuration/activation state and the migratory capacity of different DC precursor subsets in SLE to further elucidate their role in autoimmunity.

Methods: Plasmacytoid DCs (pDCs), myeloid DCs (mDCs) and monocytes from SLE patients, healthy volunteers, and healthy volunteers immunized with tetanus/diphtheria were examined by flow cytometry for expression of subset specific antigens (BDCA-2, CD11c, CD14, HLA-DR), activation/maturation markers (CD83, CD86, CD40, BLyS) and chemokine receptors (CCR1, CCR5, CCR7, ChemR23). Additionally, migratory capacity to chemokine receptors was investigated in vitro using the chemokines RANTES, CCL19 and chemerin.

Results: SLE monocytes and myeloid DCs had higher CD86 (p=0.04) and BLyS expression levels (p=0.0008). ChemR23 expression was lower in SLE plasmacytoid (p = 0.004) and myeloid DCs (p = 0.03). Basal (p= 0.004) and CCL19-specific migration levels (p=0.004) were higher in SLE plasmacytoid DCs. Altered DC function in SLE had no correlative changes in chemokine receptor expression whereas immunization-induced blood DC migration patterns in healthy donors were accompanied by changes in chemokine receptor expression.

Conclusions: The phenotypic and migratory disturbances observed in SLE blood DCs could result in altered distribution of DCs in peripheral tissues, contributing to dysregulated immune responses and autoimmunity.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs